Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the third quarter ended September 30, 2025. The update, including a webcast slide presentation with additional ...
Learn how interest from savings accounts, including HYSAs and CDs, is taxed. Understand reporting requirements and strategies ...
− 4% organic revenue growth (using fixed exchange rates and a comparable group structure) − Net sales increased by 0% to 1,303.8 MEUR (1,299.8) − Net sales including the reduction of acquired deferred ...
Analysts provided their opinions on this AI giant. The artificial intelligence wave has positioned Oracle as the key AI infrastructure development player. This apparent position overshadowed the ...
Sept 25 (Reuters) - Accenture (ACN.N), opens new tab beat fourth-quarter revenue estimates and unveiled a six‑month, $865 million restructuring to realign its workforce and operations for rising ...
OLYMPIA – A slowing economy will force cuts to services, higher taxes or both next year as the Legislature eyes increasingly dire economic news. The latest economic forecast from the Washington State ...
Commerce Secretary Howard Lutnick indicated the Trump administration is looking to take a cut of the revenue generated by university patents developed through federally funded research. Lutnick in an ...
I am upgrading NetEase to "Buy," driven by a more favorable regulatory environment and a positive Q3 outlook. Recent surge in Chinese game approvals signals a supportive policy shift, justifying a ...
Reflects estimated adjustments for share-based compensation expense of approximately $554 million; amortization of other acquired intangible assets of approximately $121 million; and amortization of ...
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best Russell 2000 stocks to buy now. On August 18, Truist Securities lowered its price target on Hims & Hers from $48 to $37, while maintaining a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results